BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
8/26/2014 3:10:00 PM | Browse: 1023 | Download: 1030
Publication Name World Journal of Hepatology
Manuscript ID 7205
Country Italy
Received
2013-11-08 20:50
Peer-Review Started
2013-11-10 14:38
To Make the First Decision
2014-01-16 08:31
Return for Revision
2014-03-04 09:08
Revised
2014-03-19 01:38
Second Decision
2014-05-29 15:48
Accepted by Journal Editor-in-Chief
Accepted by Company Editor-in-Chief
2014-05-29 15:57
Articles in Press
2014-05-29 15:57
Publication Fee Transferred
Edit the Manuscript by Language Editor
Typeset the Manuscript
2014-07-22 17:20
Publish the Manuscript Online
2014-07-25 16:43
ISSN 1948-5182 (online)
Open Access
Copyright
Article Reprints For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website http://www.wjgnet.com
Category Parasitology
Manuscript Type Review
Article Title Juvenile autoimmune hepatitis: Spectrum of the disease
Manuscript Source Invited Manuscript
All Author List Giuseppe Maggiore, Silvia Nastasio and Marco Sciveres
Funding Agency and Grant Number
Corresponding Author Giuseppe Maggiore, MD, Department of Clinical and Experimental Medicine, Pediatric Gastroenterology, University Hospital of Pisa, Via Roma 67, 56127 Pisa, Italy. giuseppe.maggiore@med.unipi.it
Key Words Juvenile autoimmune hepatitis; Autoimmune hepatitis; Autoantibodies; Autoimmune liver disease; Chronic hepatitis; Acute liver failure
Core Tip Juvenile autoimmune hepatitis is an inflammatory liver disease affecting mainly young girls from infancy to late adolescence, characterized by active liver damage, elevated immunoglobulin G levels, high titers of serum non organ-specific and organ-specific autoantibodies, and interface hepatitis on liver biopsy. Two types are identified according to the autoantibody panel, with differences in the epidemiological distribution, genetic markers and clinical presentation. The most effective therapy for autoimmune hepatitis is pharmacological suppression of the immune response. Treatment should be started as soon as the diagnosis is made to avoid severe liver damage and progression of fibrosis.
Publish Date 2014-07-25 16:43
Citation Maggiore G, Nastasio S, Sciveres M. Juvenile autoimmune hepatitis: Spectrum of the disease. World J Hepatol 2014; 6(7): 464-476
URL http://www.wjgnet.com/1948-5182/full/v6/i7/464.htm
DOI http://dx.doi.org/10.4254/wjh.v6.i7.464
Full Article (PDF) WJH-6-464.pdf
Full Article (Word) WJH-6-464.doc
Manuscript File 7205-Review.doc
Answering Reviewers 7205-Answering reviewers.pdf
Copyright License Agreement 7205-Copyright assignment.PDF
Peer-review Report 7205-Peer review(s).pdf
Scientific Misconduct Check 7205-CrossCheck.jpg
Scientific Editor Work List 7205-Scientific editor work list.pdf